Hierarchical modeling of blood pressure determinants and outcomes following valsartan treatment in hypertensive patients with known comorbidities: pooled analysis of six prospective real-world studies including 11,999 patients.
Nimer S AlkhatibDiana SunKris DenhaerynckDina HamarnehYoleen Van CampLorenzo VillaHeidi BriéStefaan VancayzeeleKaren M MacDonaldIvo AbrahamPublished in: Current medical research and opinion (2020)
Valsartan-centric regimens have significant BP lowering benefits in this pooled sample of patients with known comorbidities. Many observed determinants of BP outcomes are modifiable or manageable.